Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 2 | -$0.41 | -$0.41 | -$0.41 |
Q2 2024 | 2 | -$0.40 | -$0.40 | -$0.40 |
Q3 2024 | 6 | -$0.56 | -$0.41 | -$0.49 |
Q1 2025 | 2 | -$0.54 | -$0.44 | -$0.49 |
Q2 2025 | 1 | -$0.53 | -$0.53 | -$0.53 |
Q3 2025 | 1 | -$0.53 | -$0.53 | -$0.53 |
Q4 2025 | 1 | -$0.56 | -$0.56 | -$0.56 |
Q1 2026 | 1 | -$0.50 | -$0.50 | -$0.50 |
Q2 2026 | 1 | -$0.48 | -$0.48 | -$0.48 |
Q3 2026 | 1 | -$0.50 | -$0.50 | -$0.50 |
Q4 2026 | 1 | -$0.54 | -$0.54 | -$0.54 |
Tyra Biosciences, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.41 earnings per share for the quarter, missing analysts' consensus estimates of $-0.4 by $0.01. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Tyra Biosciences, Inc. has generated $-2 earnings per share over the last year ($-1.62 diluted earnings per share) and currently has a price-to-earnings ratio of -9.91. Tyra Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/07/2024 | Q3 2024 | -$0.40 | -$0.41 | -0.01 | $0 | $0 |
08/07/2024 | Q2 2024 | -$0.41 | -$0.32 | 0.09 | $0 | $0 |
05/09/2024 | Q1 2024 | -$0.46 | -$0.35 | 0.11 | $0 | |
03/19/2024 | Q4 2023 | -$0.48 | -$0.53 | -0.05 | $502,000 | |
11/07/2023 | Q3 2023 | -$0.35 | -$0.49 | -0.14 | $0 | |
08/10/2023 | Q2 2023 | -$0.34 | -$0.31 | 0.03 | $0 | |
05/04/2023 | Q1 2023 | -$0.37 | -$0.22 | 0.15 | $0 | |
03/22/2023 | Q4 2022 | -$0.35 | $0.46 | 0.81 | $0 | |
11/03/2022 | Q3 2022 | -$0.41 | -$0.27 | 0.14 | $0 | |
08/04/2022 | Q2 2022 | -$0.33 | -$0.35 | -0.02 | $0 | |
05/05/2022 | Q1 2022 | -$0.20 | -$0.36 | -0.16 | $0 | |
03/03/2022 | Q4 2021 | -$0.21 | -$0.24 | -0.03 | $0 | |
11/03/2021 | Q3 2021 | -$0.29 | -$0.72 | -0.43 | $0 | |
06/30/2021 | Q2 2021 | -$0.15 | $0 | |||
03/31/2021 | Q1 2021 | -$0.19 | $0 | |||
12/30/2020 | Q4 2020 | -$0.16 | $0 | |||
09/29/2020 | Q3 2020 | -$0.10 | $0 | |||
06/29/2020 | Q2 2020 | -$1.27 | $0 | |||
03/30/2020 | Q1 2020 | -$1.07 | $0 |
Tyra Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based off last year's report dates.
The conference call for Tyra Biosciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Tyra Biosciences, Inc.'s latest earnings report can be read online.
Tyra Biosciences, Inc. (:TYRA) has a recorded net income of $0. Tyra Biosciences, Inc. has generated $-1.62 earnings per share over the last four quarters.
Tyra Biosciences, Inc. (:TYRA) has a price-to-earnings ratio of -9.91 and price/earnings-to-growth ratio is -2.09.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED